Literature DB >> 9013396

Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolism.

M Naumann1, M Götz, K Reiners, K W Lange, P Riederer.   

Abstract

While several radiological findings point towards the basal ganglia as a possible anatomical site of the lesion in dystonia patients the biochemical basis of the disorder is still unknown. 5-Hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) levels-the respective metabolites of serotonin and dopamine-were measured in lumbar cerebrospinal fluid (lCSF) of 15 patients with idiopathic adult-onset focal dystonia and in lCSF of 11 controls. 100 microliters lCSF were analyzed for 5-HIAA and HVA by reversed-phase HPLC with electrochemical detection. 5-HIAA levels were significantly reduced in dystonia patients (11.4 micrograms/ml) compared to controls (18.4 ng/ml) (p < 0.02). HVA levels in dystonia patients (30.3 ng/ml) were below control values (41.6 ng/ml) but this finding did not reach statistical significance. Decreased lCSF levels of 5-HIAA suggest an impaired serotonin metabolism in patients with idiopathic adult-onset dystonia. This observation may provide a biochemical basis for a more specific pharmacotherapy in dystonia patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9013396     DOI: 10.1007/BF01291793

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  38 in total

1.  Acute dystonia and fluoxetine.

Authors:  B Black; T W Uhde
Journal:  J Clin Psychiatry       Date:  1992-09       Impact factor: 4.384

2.  5-Hydroxyindoleacetic acid in cerebrospinal fluid--methodological and clinical aspects.

Authors:  L Bertilsson
Journal:  Life Sci       Date:  1987-08-17       Impact factor: 5.037

3.  Personality in torticollis: a controlled study.

Authors:  M Jahanshahi; C D Marsden
Journal:  Psychol Med       Date:  1988-05       Impact factor: 7.723

4.  Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness.

Authors:  R M Post; J Kotin; F K Goodwin; E K Gordon
Journal:  Am J Psychiatry       Date:  1973-01       Impact factor: 18.112

5.  Biochemical and pharmacologic studies of dystonia.

Authors:  T N Chase
Journal:  Neurology       Date:  1970-11       Impact factor: 9.910

Review 6.  A proposed new nomenclature for 5-HT receptors.

Authors:  P P Humphrey; P Hartig; D Hoyer
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

7.  Levodopa-induced dyskinesias are improved by fluoxetine.

Authors:  F Durif; M Vidailhet; A M Bonnet; J Blin; Y Agid
Journal:  Neurology       Date:  1995-10       Impact factor: 9.910

8.  Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias.

Authors:  S M Stahl; P A Berger
Journal:  Neurology       Date:  1982-08       Impact factor: 9.910

9.  Acetylcholinesterase activity in patients with torsion dystonia. Measurement in erythrocyte membranes.

Authors:  W A Maltese; S Bressman; S Fahn; D C De Vivo
Journal:  Arch Neurol       Date:  1985-02

10.  Concentrations of GABA and other amino acids in CSF from torsion dystonia patients.

Authors:  T L Perry; S Hansen; N Quinn; C D Marsden
Journal:  J Neurochem       Date:  1982-10       Impact factor: 5.372

View more
  6 in total

1.  Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid.

Authors:  J J Luykx; S C Bakker; E Lentjes; M Neeleman; E Strengman; L Mentink; J DeYoung; S de Jong; J H Sul; E Eskin; K van Eijk; J van Setten; J E Buizer-Voskamp; R M Cantor; A Lu; M van Amerongen; E P A van Dongen; P Keijzers; T Kappen; P Borgdorff; P Bruins; E M Derks; R S Kahn; R A Ophoff
Journal:  Mol Psychiatry       Date:  2013-01-15       Impact factor: 15.992

Review 2.  Monoamine neurotransmitter disorders--clinical advances and future perspectives.

Authors:  Joanne Ng; Apostolos Papandreou; Simon J Heales; Manju A Kurian
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

3.  Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders.

Authors:  Elisa De Grandis; Mercedes Serrano; Belén Pérez-Dueñas; Aida Ormazábal; Raquel Montero; Edvige Veneselli; Mercè Pineda; Verónica González; Francesc Sanmartí; Carmen Fons; Anna Sans; Bru Cormand; Luis Puelles; Antonia Alonso; Jaime Campistol; Rafael Artuch; Angels García-Cazorla
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

4.  Sleep and other Non-motor Symptoms in Patients with Idiopathic Oromandibular Dystonia and Meige Syndrome: A Questionnaire-based Study.

Authors:  Somdattaa Ray; Bindu Kutty; Pramod Kumar Pal; Ravi Yadav
Journal:  Ann Indian Acad Neurol       Date:  2021-07-01       Impact factor: 1.383

5.  Lower serotonin transporter binding in patients with cervical dystonia is associated with psychiatric symptoms.

Authors:  E Zoons; J Booij; J D Speelman; Y E M Dreissen; M Smit; M A J Tijssen
Journal:  EJNMMI Res       Date:  2017-10-25       Impact factor: 3.138

6.  Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.

Authors:  Lingyan Ma; Jing Keng; Min Cheng; Hua Pan; Bo Feng; Yongfeng Hu; Tao Feng; Fan Yang
Journal:  mSphere       Date:  2021-08-04       Impact factor: 4.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.